Wall Street Is Counting Out The Biggest Breakthrough In Medicine – Here’s How To Make Their Mistake Into Your Gain

Not to worry, Cathy Wood has you covered. She’s focused on the elite genomics players that will deliver over the long haul.

Her genomics-focused ETF is ARK Genomic Revolution ETF (ARKG). For this fund, Wood picks companies involved in pushing forward genomic technologies such as CRISPR, a form of gene editing. The fund also targets genomic treatments, genetic diagnostics, agricultural biology, stem cells, and so on.

These are the companies that will benefit hugely from the advances being made in genomics. They will revolutionize our healthcare, bring about personalized diagnostics and treatments, and optimize our food supply to boot.

Some of the best ones include:

  1. Editas Medicine Inc. (EDIT), backed by Bill Gates among others, is one of the world’s leading companies in the CRISPR gene editing space. Last March, the firm was the first in the world to inject CRISPR into a living human, as part of its ongoing trials to cure and reverse certain kinds of blindness by rewriting the DNA in the patients’ eyes.
  2. Beam Therapeutics Inc. (BEAM) is also developing gene-editing treatments, but uses a slightly different method than CRISPR – one that’s supposed to be more accurate. The firm has two gene treatments for leukemia currently in the pre-clinical stages of development and is doing research with an eye to correct small mutations that cause severe or even fatal liver and eye diseases.
  3. Fate Therapeutics Inc. (FATE) focuses on extracting and reprogramming immune stem cells. The goal is to make them more active against cancers or in cases of immune diseases, less active against the body’s own cells. By doing this outside the body, Fate can achieve more exact control over how the stem cells are reprogrammed. The firm already has four treatments through Phase 1 trials.
  4. Berkeley Lights Inc. (BLI) has created the integrated platform that makes genomics work like this possible, by enabling researchers to quickly and accurately find and isolate the exact cells they’re looking for. Using their integrated, custom-made chips, reagents, machines, and software, Berkeley Lights lets scientists increase the speed and scale of finding the right antibodies – or correctly identify where an immune cell comes from and all its properties.
View single page >> |

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.